- Home
- DEC vs QTRX Comparison
DEC vs QTRX Comparison
Compare DEC & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEC
- QTRX
- Stock Information
- Founded
- DEC 2001
- QTRX 2007
- Country
- DEC United States
- QTRX United States
- Employees
- DEC N/A
- QTRX N/A
- Industry
- DEC
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- DEC
- QTRX Industrials
- Exchange
- DEC Nasdaq
- QTRX Nasdaq
- Market Cap
- DEC 538.9M
- QTRX 492.0M
- IPO Year
- DEC N/A
- QTRX 2017
- Fundamental
- Price
- DEC $11.62
- QTRX $12.41
- Analyst Decision
- DEC Strong Buy
- QTRX Strong Buy
- Analyst Count
- DEC 2
- QTRX 4
- Target Price
- DEC $18.50
- QTRX $23.00
- AVG Volume (30 Days)
- DEC 231.5K
- QTRX 363.3K
- Earning Date
- DEC 01-01-0001
- QTRX 11-04-2024
- Dividend Yield
- DEC 9.96%
- QTRX N/A
- EPS Growth
- DEC N/A
- QTRX N/A
- EPS
- DEC 3.00
- QTRX N/A
- Revenue
- DEC $699,472,000.00
- QTRX $129,330,000.00
- Revenue This Year
- DEC $13.18
- QTRX $13.56
- Revenue Next Year
- DEC $24.63
- QTRX $16.70
- P/E Ratio
- DEC $3.88
- QTRX N/A
- Revenue Growth
- DEC N/A
- QTRX 15.52
- 52 Week Low
- DEC $10.54
- QTRX $10.50
- 52 Week High
- DEC $17.10
- QTRX $29.70
- Technical
- Relative Strength Index (RSI)
- DEC 45.80
- QTRX 49.39
- Support Level
- DEC $11.63
- QTRX $10.96
- Resistance Level
- DEC $11.92
- QTRX $12.97
- Average True Range (ATR)
- DEC 0.28
- QTRX 0.61
- MACD
- DEC 0.05
- QTRX 0.07
- Stochastic Oscillator
- DEC 46.81
- QTRX 61.18
About DEC Diversified Energy Company plc
Diversified Energy Co PLC is an independent owner and operator of producing natural gas and oil wells concentrated in the Appalachian Basin. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.